- ￥3000 - 3999
- Abbiotec
- 美国
- 250687
- 2025年07月14日
- E, WB, IHC
- Rabbit
- Vs
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of hepatitis virus C NS4A.
- 亚型：
Rabbit Ig
- 形态：
Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.
- 保存条件：
Store at -20°C.
- 克隆性：
多克隆抗体
- 标记物：
见下方详细说明
- 适应物种：
Vs
- 宿主：
Rabbit
- 应用范围：
E, WB, IHC
- 浓度：
见详细说明信息
- 靶点：
HCV-NS4a
- 抗体英文名：
HCV-NS4a Antibody
- 抗体名：
HCV-NS4a Antibody
- 规格：
0.1 mg
HCV-NS4a Antibody产品详细介绍：
| 产品名称： | HCV-NS4a Antibody |
| 说明书： | http://www.abbiotec.com/antibodies/hcv-ns4a-antibody【参考图片】 |
| 货号： | 250687 |
| 规格： | 0.1 mg |
| 产品描述： | Hepatitis C virus (HCV) non-structural protein 4A (NS4A) in association with NS3 is involved in the cleavage of NS3-NS4A, NS4A-NS4B, NS4B-NS5B and NS5B-NS5B. NS4A interacts with NS3 serine protease and stabilizes its folding. NS3/NS4A complex also prevents phosphorylation of human IRF3, thus preventing the establishment of dsRNA induced antiviral state. |
| 克隆类型： | Rabbit Polyclonal Antibody |
| 亚型： | Rabbit Ig |
| 免疫原： | KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of hepatitis virus C NS4A. |
| 适用物种： | Vs |
| 应用范围： | E, WB, IHC |
| 应用说明： | E: 1:500-1:1,000; WB: 1:100-1:500; IHC: 1:100-1:500 |
| 别名： | Genome polyprotein hepatitis C virus; Non-structural protein 4A; NS4A; p8 |
| 形态： | Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography. |
| 保存条件： | Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment. |
| 参考文献： |
ABBIOTEC产品提供质量保证，提供完善的售后和技术支持，ABBIOTEC产品正品包装：
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Simultaneous Detection of Anti-HCV Antibody and HCV Core Antigen
HCV infection is usually diagnosed by means of an enzyme immune assay for the detection of antibody against HCV. The window period between infection and seroconversion remains a dramatic problem in the transfusional and diagnostic setting
The AMPLICOR HCV Tests for the Detection and Quantitation of Serum or Plasma HCV RNA
infection, but cannot be considered a marker for current infection. Nor can anti-HCV antibody levels be used to monitor response to therapeutic agents. Finally, in cases of acute HCV infection resulting from accidental needlestick exposure, many patients
Studying HCV Cell Entry with HCV Pseudoparticles (HCVpp)
HCV infection leads in 50 to 80% of cases to chronic hepatitis, liver cirrhosis, or hepatocellular carcinoma. Interferons and the nucleoside analog ribavirin form the basis for treatment but are not sufficiently effective and have numerous
技术资料暂无技术资料 索取技术资料
